Trials / Completed
CompletedNCT01353287
Transcatheter Aortic Valve Intervention-Live Transmission
Transcatheter Aortic Valve Intervention-Live Transmission (VERITAS)Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 110 (actual)
- Sponsor
- Medstar Health Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this clinical trial is to evaluate safety of patients who underwent Transcatheter Aortic Valve Intervention (TAVI) during a live case or video-taped transmission as compared to those without procedure transmission.
Detailed description
A series of sites from outside the US, where the Edwards-Sapien and CoreValve devices are approved for commercial sale and implantation, will be recruited to retrospectively identify and extract in-hospital data of a patient who underwent TAVI during a live or video-taped procedure and a matched patient who underwent TAVI without transmission of the procedure.
Conditions
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2011-05-13
- Last updated
- 2013-08-01
Locations
6 sites across 6 countries: United States, Canada, Germany, Italy, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT01353287. Inclusion in this directory is not an endorsement.